Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Anagha Deshpande & Javier Munoz. (2022) Zanubrutinib in Treating Waldenström Macroglobulinemia, the Last Shall Be the First. Therapeutics and Clinical Risk Management 18, pages 657-668.
Read now
Read now
Ulku Unal, Betul Comertpay, Talip Yasir Demirtas & Esra Gov. (2022) Drug repurposing for rheumatoid arthritis: Identification of new drug candidates via bioinformatics and text mining analysis. Autoimmunity 55:3, pages 147-156.
Read now
Read now
Liangliang Li, Ye Chai, ChongYang Wu & Li Zhao. (2020) Chemokine receptor CXCR4: An important player affecting the molecular-targeted drugs commonly used in hematological malignancies. Expert Review of Hematology 13:12, pages 1387-1396.
Read now
Read now
Articles from other publishers (9)
Shao-Liang Jiang, Li Li, Lu Hu, Song-Bo Kou & Jie-Hua Shi. (2023) Comprehending binding features between ibrutinib and Human Alpha-1 acid glycoprotein: Combined experimental approaches and theoretical simulations. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 285, pages 121834.
Crossref
Crossref
Mohamed A. Abdelgawad, Nadia A.A. Elkanzi, A.A. Nayl, Arafa Musa, Nasser Hadal Alotaibi, W.A.A. Arafa, Sobhi M. Gomha & Rania B. Bakr. (2022) Targeting tumor cells with pyrazolo[3,4-d]pyrimidine scaffold: A literature review on synthetic approaches, structure activity relationship, structural and target-based mechanisms. Arabian Journal of Chemistry 15:5, pages 103781.
Crossref
Crossref
Maša Kenda, Damjan Avsec, Taja Zore, Eva Kogovšek, Urša Pečar Fonović, Janko Kos, Krištof Bozovičar, Tomaž Bratkovič, Nataša Karas Kuželički, Bojana Žegura, Metka Filipič & Marija Sollner Dolenc. (2022) Effects of tyrosine kinase inhibitors on androgen, estrogen α, glucocorticoid and thyroid receptors. Toxicology and Applied Pharmacology 434, pages 115818.
Crossref
Crossref
Kaleigh E. Lindholm, Peter A. Forsberg & Mark D. Ewalt. (2021) Ibrutinib response in cutaneous transformed lymphoplasmacytic lymphoma. eJHaem 2:3, pages 565-568.
Crossref
Crossref
Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Despina Fotiou & Meletios A. Dimopoulos. (2021) Current and novel BTK inhibitors in Waldenström’s macroglobulinemia. Therapeutic Advances in Hematology 12, pages 204062072198958.
Crossref
Crossref
Amy L. Whillock, Tiffany K. Ybarra & Gail A. Bishop. (2021) TNF receptor-associated factor 3 restrains B-cell receptor signaling in normal and malignant B cells. Journal of Biological Chemistry 296, pages 100465.
Crossref
Crossref
Chao Xue, Xin Wang, Lingyan Zhang, Qingyuan Qu, Qian Zhang & Yujie Jiang. (2020) Ibrutinib in B-cell lymphoma: single fighter might be enough?. Cancer Cell International 20:1.
Crossref
Crossref
Parathan Karunakaran. (2021) Drug Review: Ibrutinib. Indian Journal of Medical and Paediatric Oncology 41:03, pages 383-392.
Crossref
Crossref
Stefania Scala, Crescenzo D’Alterio, Samantha Milanesi, Alessandra Castagna, Roberta Carriero, Floriana Maria Farina, Massimo Locati & Elena Monica Borroni. (2020) New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM. Vaccines 8:2, pages 164.
Crossref
Crossref